News & Announcements
PerkinElmer Invests in Carterra, the Leader in Label-Free High Throughput Antibody Screening and Characterization
Carterra, Inc., the world leader in label-free high throughput antibody screening and characterization, today announced that they have closed on a round of equity financing led by PerkinElmer, Inc. Current Carterra investors Telegraph Hill Partners and Ballast Point Ventures also participated in the [...]
Specific Diagnostics Announces Designation as an ISO-13485-Compliant Medical Device Manufacturer
December 2, 2020 - MOUNTAIN VIEW, California – FOR IMMEDIATE RELEASE Specific Diagnostics today announced that it has received ISO-13485 certification through the International Organization for Standardization. A QMS conforming to ISO-13485 meets the highest FDA standards applicable to the manufact [...]
Agena Bioscience Granted EUA for High-Throughput, Low-Cost SARS-CoV-2 Panel
Agena Bioscience®, a global provider of low-cost and high-throughput molecular testing solutions, today announced that its MassARRAY® SARS-CoV-2 Panel for qualitative detection of the SARS-CoV-2 coronavirus has been granted Emergency Use Authorization from the U.S. Food and Drug Administration (FDA) [...]
Precision NanoSystems Receives $18.2 Million from the Government of Canada to Develop an RNA Vaccine for COVID-19
PNI will use the investment to advance a cost-effective Made-in-Canada COVID-19 vaccine PNI offers expertise in self-amplifying mRNA vectors, lipid-based drug delivery systems and nanomedicine manufacturing PNI will contribute to Canada’s ability to secure an effective COVID-19 vaccine and build tec [...]
Nimble Announces Strategic Research Collaboration with Incyte to Discover Novel Peptide-Based Therapeutics
Madison, WI, USA, October 5, 2020 — Nimble Therapeutics Inc. today announced the company has entered into a strategic collaboration with Incyte (NASDAQ: INCY) to discover first-in-class peptide therapies across various disease areas. “This is an important collaboration for both companies to discover [...]
Agena Bioscience Launches High-Throughput, Low-Cost SARS-CoV-2 Detection Panel in Europe with CE-IVD Marking
San Diego, CA – Agena Bioscience, a global provider of low cost and high-throughput molecular testing solutions, today announced that it has obtained CE-IVD marking for its SARS-CoV-2 Panel, an in vitro diagnostic test for the qualitative detection of the SARS-CoV-2 coronavirus that causes COVID-19. [...]
A New SARS-CoV-2 Spike Protein Biosensor Chip was Successfully Deployed for Simultaneous Measurements of IgG, IgA, and IgM Using Only 2 µL of Serum per Patient
Salt Lake City, Utah. Carterra® Inc., the world leader in high-throughput antibody screening and characterization, has announced the availability of a highly accurate assay for simultaneously measuring the concentration and binding of IgG, IgM, and IgA antibodies to the Receptor Binding Domain (RBD) [...]